Chronic kidney disease affects people worldwide. Approximately 1 out of 3 adults with diabetes have kidney disease. Among several etiological factors for CKD, diabetes mellitus (DM) and hypertension are the main factors. These factors not only cause CKD but are also responsible for several complications related to CKD. In this article, we have reviewed Diabetic Nephropathy (DN) in terms of etiology, pathophysiology, diagnosis, management, current guidelines for diabetic nephropathy management, and some of the research study findings. Diabetic nephropathy (DN) is the chief factor for end-stage renal disease (ESRD) development across the globe. The primary cause of DN is Diabetes Mellitus, which is an autoimmune lifestyle disorder having several etiological factors. Checking for urine albuminuria, estimated GFR (eGFR), and blood glucose are unswerving tests for DN diagnosis and subsequent monitoring. Controlling hyperglycemia, blood pressure, and proteinuria are critical in stopping the progression of DKD. Clinical practice and evidence-based medicine demonstrated that early diagnosis followed by treatment can prevent or halt DKD progression.
Deng, Y.J., et al. (2021) Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease from 1990 to 2019. Frontiers in Endocrinology, 12, Article 672350. https://www.frontiersin.org/articles/10.3389/fendo.2021.672350/full
Umanath, K. and Lewis, J.B. (2018) Update on Diabetic Nephropathy: Core Curriculum 2018. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation, 71, 884-895. https://doi.org/10.1053/j.ajkd.2017.10.026
Rabkin, R. (2003) Diabetic Nephropathy. Clinical Cornerstone, 5, 1-11. https://doi.org/10.1016/S1098-3597(03)90014-7
Garg, J.P. and Bakris, G.L. (2002) Microalbuminuria: Marker of Vascular Dysfunction, Risk Factor for Cardiovascular Disease. Vascular Medicine, 7, 35-43. https://doi.org/10.1191/1358863x02vm412ra
Diabetes Canada Clinical Practice Guidelines Expert Committee, McFarlane, P., Cherney, D., Gilbert, R.E. and Senior, P. (2018) Chronic Kidney Disease in Diabetes. Canadian Journal of Diabetes, 42, S201-S209. https://doi.org/10.1016/j.jcjd.2017.11.004
Statista (2023) Percentage of Adults with Prediabetes by Age U.S. 2017-2020.
Vasbinder, A., et al. (2022) Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals with Diabetes Mellitus Hospitalized for COVID-19. Diabetes Care, 45, 692-700. https://doi.org/10.2337/dc21-2102
Bakris, G.L (2022) Mechanisms of Glomerular Hyperfiltration in Diabetes Mellitus. Up-ToDate.
Chen, J., Liu, Q., He, J. and Li, Y. (2022) Immune Responses in Diabetic Nephropathy: Pathogenic Mechanisms and Therapeutic Target. Frontiers in Immunology, 13, Article 958790. https://doi.org/10.3389/fimmu.2022.958790
Tangri, N., Stevens, L.A., Griffith, J., Tighiouart, H., Djurdjev, O., Naimark, D., Levin, A. and Levey, A.S. (2011) A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure. The Journal of the American Medical Association, 305, 1553-1559. https://doi.org/10.1001/jama.2011.451
American Diabetes Association (2019) 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019. Diabetes Care, 42, S124-S138. https://doi.org/10.2337/dc19-S011
Levey, A.S., Atkins, R., Coresh, J., Cohen, E.P., Collins, A.J., Eckardt, K.U., Nahas, M.E., Jaber, B.L., Jadoul, M., Levin, A., Powe, N.R., Rossert, J., Wheeler, D.C., Lameire, N. and Eknoyan, G. (2007) Chronic Kidney Disease as a Global Public Health Problem: Approaches and Initiatives—A Position Statement from Kidney Disease Improving Global Outcomes. Kidney International, 72, 247-259. https://doi.org/10.1038/sj.ki.5002343
Inker, L.A., Astor, B.C., Fox, C.H., Isakova, T., Lash, J.P., Peralta, C.A., Kurella Tamura, M. and Feldman, H.I. (2014) KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation, 63, 713-735. https://doi.org/10.1053/j.ajkd.2014.01.416
James, P.A., Oparil, S., Carter, B.L., et al. (2014) 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). The Journal of the American Medical Association, 311, 507-520. https://doi.org/10.1001/jama.2013.284427
Levin, A., et al. (2013) Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements, 3, 1-150.
Fried, L.F., Emanuele, N., Zhang, J.H., Brophy, M., Conner, T.A., Duckworth, W., Leehey, D.J., McCullough, P.A., O’Connor, T., Palevsky, P.M., Reilly, R.F., Seliger, S.L., Warren, S.R., Watnick, S., Peduzzi, P., Guarino, P. and VA NEPHRON-D Investigators (2013) Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy. The New England Journal of Medicine, 369, 1892-1903. https://doi.org/10.1056/NEJMoa1303154
ONTARGET Investigators, Yusuf, S., Teo, K.K., Pogue, J., Dyal, L., Copland, I., Schumacher, H., Dagenais, G., Sleight, P. and Anderson, C. (2008) Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events. The New England Journal of Medicine, 358, 1547-1559. https://doi.org/10.1056/NEJMoa0801317
Zannad, F., Rossignol, P., Stough, W.G., Epstein, M., de los Angeles Alonso Garcia, M., Bakris, G.L., Butler, J., Kosiborod, M., Berman, L., Mebazaa, A., Rasmussen, H.S., Ruilope, L.M., Stockbridge, N., Thompson, A., Wittes, J. and Pitt, B. (2016) New Approaches to Hyperkalemia in Patients with Indications for Renin Angiotensin Aldosterone Inhibitors: Considerations for Trial Design and Regulatory Approval. International Journal of Cardiology, 216, 46-51. https://doi.org/10.1016/j.ijcard.2016.04.127
Fouli, G.E. and Gnudi, L. (2018) The Future: Experimental Therapies for Renal Disease in Diabetes. Nephron, 143, 3-7. https://www.karger.com/nef/article/143/1/3/221957/The-Future-Experimental-Therapies-for-Renal
Genuth, S., Eastman, R., Kahn, R., Klein, R., Lachin, J., Lebovitz, H., Nathan, D., Vinicor, F. and American Diabetes Association (2003) Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care, 26, s28-s32. https://doi.org/10.2337/diacare.26.2007.S28
DCCT/EDIC Research Group (2014) Effect of Intensive Diabetes Treatment on Albuminuria in Type 1 Diabetes: Long-Term Follow-Up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications Study. The Lancet Diabetes & Endocrinology, 2, 793-800. https://doi.org/10.1016/S2213-8587(14)70155-X
Brenner, B.M., Cooper, M.E., de Zeeuw, D., Keane, W.F., Mitch, W.E., Parving, H.H., Remuzzi, G., Snapinn, S.M., Zhang, Z., Shahinfar, S. and RENAAL Study Investigators (2001) Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy. The New England Journal of Medicine, 345, 861-869. https://doi.org/10.1056/NEJMoa011161
Lewis, E.J., Hunsicker, L.G., Clarke, W.R., Berl, T., Pohl, M.A., Lewis, J.B., Ritz, E., Atkins, R.C., Rohde, R., Raz, I. and Collaborative Study Group (2001) Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes. The New England Journal of Medicine, 345, 851-860. https://doi.org/10.1056/NEJMoa011303
Filippatos, G., Anker, S.D., Böhm, M., Gheorghiade, M., Køber, L., Krum, H., Maggioni, A.P., Ponikowski, P., Voors, A.A., Zannad, F., Kim, S.Y., Nowack, C., Palombo, G., Kolkhof, P., Kimmeskamp-Kirschbaum, N., Pieper, A. and Pitt, B. (2016) A Randomized Controlled Study of Finerenone vs. Eplerenone in Patients with Worsening Chronic Heart Failure and Diabetes Mellitus and/or Chronic Kidney Disease. European Heart Journal, 37, 2105-2114. https://doi.org/10.1093/eurheartj/ehw132
Rastogi, A. and Bhansali, A. (2017) SGLT2 Inhibitors through the Windows of EMPAREG and CANVAS Trials: A Review. Diabetes Therapy: Research, Treatment and Education of Diabetes and Related Disorders, 8, 1245-1251. https://doi.org/10.1007/s13300-017-0320-1
Haraguchi, R., Kohara, Y., Matsubayashi, K., Kitazawa, R. and Kitazawa, S. (2020) New Insights into the Pathogenesis of Diabetic Nephropathy: Proximal Renal Tubules Are Primary Target of Oxidative Stress in Diabetic Kidney. Acta Histochemica et Cytochemica, 53, 21-31. https://doi.org/10.1267/ahc.20008